These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37882064)

  • 1. A SNAI2/CTCF Interaction is Required for
    Sreenivas P; Wang L; Wang M; Challa A; Modi P; Hensch NR; Gryder B; Chou HC; Zhao XR; Sunkel B; Moreno-Campos R; Khan J; Stanton BZ; Ignatius MS
    Mol Cell Biol; 2023; 43(11):547-565. PubMed ID: 37882064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
    Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
    Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.
    Hensch NR; Bondra K; Wang L; Sreenivas P; Zhao XR; Modi P; Vaseva AV; Houghton PJ; Ignatius MS
    Mol Cancer Ther; 2023 Jan; 22(1):123-134. PubMed ID: 36162055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNAI2-Mediated Repression of
    Wang L; Hensch NR; Bondra K; Sreenivas P; Zhao XR; Chen J; Moreno Campos R; Baxi K; Vaseva AV; Sunkel BD; Gryder BE; Pomella S; Stanton BZ; Zheng S; Chen EY; Rota R; Khan J; Houghton PJ; Ignatius MS
    Cancer Res; 2021 Nov; 81(21):5451-5463. PubMed ID: 34462275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.
    Bailey CG; Metierre C; Feng Y; Baidya K; Filippova GN; Loukinov DI; Lobanenkov VV; Semaan C; Rasko JE
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.
    Khoury A; Achinger-Kawecka J; Bert SA; Smith GC; French HJ; Luu PL; Peters TJ; Du Q; Parry AJ; Valdes-Mora F; Taberlay PC; Stirzaker C; Statham AL; Clark SJ
    Nat Commun; 2020 Jan; 11(1):54. PubMed ID: 31911579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
    Kang J; Kim YW; Park S; Kang Y; Kim A
    FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy.
    Vrenken KS; Vervoort BMT; van Ingen Schenau DS; Derks YHW; van Emst L; Grytsenko PG; Middelbeek JAJ; van Leeuwen FN
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165644. PubMed ID: 31862304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTCF modulates allele-specific sub-TAD organization and imprinted gene activity at the mouse Dlk1-Dio3 and Igf2-H19 domains.
    Llères D; Moindrot B; Pathak R; Piras V; Matelot M; Pignard B; Marchand A; Poncelet M; Perrin A; Tellier V; Feil R; Noordermeer D
    Genome Biol; 2019 Dec; 20(1):272. PubMed ID: 31831055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
    Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
    Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
    Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
    Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
    De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
    PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
    Kim J; Kang J; Kim YW; Kim A
    FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active enhancers strengthen insulation by RNA-mediated CTCF binding at chromatin domain boundaries.
    Islam Z; Saravanan B; Walavalkar K; Farooq U; Singh AK; Radhakrishnan S; Thakur J; Pandit A; Henikoff S; Notani D
    Genome Res; 2023 Jan; 33(1):1-17. PubMed ID: 36650052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of directionality of chromatin folding for the inter- and intra-domain contacts at the Tfap2c-Bmp7 locus.
    Tsujimura T; Takase O; Yoshikawa M; Sano E; Hayashi M; Takato T; Toyoda A; Okano H; Hishikawa K
    Epigenetics Chromatin; 2018 Sep; 11(1):51. PubMed ID: 30213272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local chromatin interactions contribute to expression of the fibrinogen gene cluster.
    Espitia Jaimes C; Fish RJ; Neerman-Arbez M
    J Thromb Haemost; 2018 Oct; 16(10):2070-2082. PubMed ID: 30039577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation.
    Fang C; Wang Z; Han C; Safgren SL; Helmin KA; Adelman ER; Serafin V; Basso G; Eagen KP; Gaspar-Maia A; Figueroa ME; Singer BD; Ratan A; Ntziachristos P; Zang C
    Genome Biol; 2020 Sep; 21(1):247. PubMed ID: 32933554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
    Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
    Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key role for CTCF in establishing chromatin structure in human embryos.
    Chen X; Ke Y; Wu K; Zhao H; Sun Y; Gao L; Liu Z; Zhang J; Tao W; Hou Z; Liu H; Liu J; Chen ZJ
    Nature; 2019 Dec; 576(7786):306-310. PubMed ID: 31801998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTCF boundary remodels chromatin domain and drives aberrant
    Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
    Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.